'Pharmacist only' medicines

被引:11
作者
Bessell, TL [1 ]
Hiller, JE
Sansom, LN
机构
[1] Univ Adelaide, Dept Publ Hlth, Adelaide, SA 5005, Australia
[2] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
关键词
D O I
10.1111/j.1467-842X.1999.tb01557.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
While there is a global trend to switch medicines from prescription to nonprescription status, Australia has created a unique schedule of pharmacist only medicines' (POM). Such medicines may provide consumers with greater choice and control of health care decisions. However, the impact of these actions has not been evaluated. Public health concerns including the appropriate use of medicines, awareness and equity of access to POM, and access to information on POM are discussed using antifungal vaginal products as an example. The National Medicines Policy advocates a partnership approach to achieve improved health outcomes by the quality use of medicines, however currently no data on POM are available. Recommendations include changes to legislation, public health data collection and the provision of quality information including pharmaceutical and non-pharmaceutical interventions.
引用
收藏
页码:661 / 662
页数:2
相关论文
共 8 条
[1]  
*AUSTR HLTH MIN AD, 1997, GUID NAT DRUGS POIS
[2]  
*COMM DEP HLTH FAM, 1997, PHARM BEN SCHEM
[3]  
*COMM DEP HLTH FAM, 1997, REV THER GOODS ADM
[4]  
*CONS HLTH FOR AUS, 1995, PHARM PROJ FIN REP
[5]  
Ferris DG, 1996, J FAM PRACTICE, V42, P595
[6]  
REEF SE, 1998, TREATMENT OPTIONS VU
[7]  
Sansom L, 1999, J Qual Clin Pract, V19, P31, DOI 10.1046/j.1440-1762.1999.00291.x
[8]  
1998, AUST J PHARM, V79, P1226